embecta to Participate in Upcoming Investor Conferences in May

Rhea-AI Summary

Embecta Corp. (Nasdaq: EMBC) has announced its participation in two significant investor conferences. The 2022 RBC Capital Markets Global Healthcare Conference will feature a fireside chat on May 18 at 9:30 a.m. ET at the Intercontinental NY Barclay Hotel. Furthermore, the Piper Sandler Ophthalmology and Diabetes Symposium will include a virtual fireside chat on May 25 at 12:00 p.m. ET. Both presentations will be available for replay on the company’s investor relations website.

With nearly 100 years of experience in diabetes care, Embecta aims to empower diabetes patients worldwide.

News Market Reaction – EMBC

-1.55%

1 alert

-1.55% News Effect

On the day this news was published, EMBC declined 1.55%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

PARSIPPANY, N.J., May 09, 2022 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will participate in the following upcoming investor conferences:

The 2022 RBC Capital Markets Global Healthcare Conference at the Intercontinental NY Barclay Hotel in New York, NY.

• Management will participate in a fireside chat on Wednesday, May 18 at 9:30 a.m. Eastern Time.
  

The Piper Sandler Ophthalmology and Diabetes Symposium.

• Management will participate in a virtual fireside chat on Wednesday, May 25 at 12:00 p.m. Eastern Time.
  

Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at https://investors.embecta.com/. The webcasts will be available for replay following the conference.

About embecta 
embecta, formerly part of BD (Becton, Dickinson and Company), is one of the largest pure-play diabetes care companies in the world, leveraging its nearly 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com.

CONTACTS 
 
Investors:
Contact IR

Media:
Christian Glazar
Sr. Director, Corporate Communications
908-821-6922
Christian.Glazar@embecta.com

FAQ

When is Embecta Corp. participating in the RBC Capital Markets Global Healthcare Conference?

Embecta Corp. will participate in the RBC Capital Markets Global Healthcare Conference on May 18, 2022, at 9:30 a.m. Eastern Time.

What is the date and time for Embecta's fireside chat at the Piper Sandler Ophthalmology and Diabetes Symposium?

The fireside chat at the Piper Sandler Ophthalmology and Diabetes Symposium will take place on May 25, 2022, at 12:00 p.m. Eastern Time.

Where can I access the webcasts of Embecta Corp.'s investor presentations?

Webcasts of Embecta Corp.'s presentations will be available under the 'News & Events' section on their investor relations website.

What is Embecta Corp.'s focus in the healthcare sector?

Embecta Corp. specializes in diabetes care, leveraging nearly 100 years of experience in insulin delivery to support diabetes patients.

What is the stock symbol for Embecta Corp.?

The stock symbol for Embecta Corp. is EMBC.